FDA Approves Cholesterol Lowering Drug Repetha

April 26, 2023 3:48 pm87 commentsViews: 2227

FDA approved today Repatha, the second drug in its class for the treatment of high cholesterol.

FDA Approves Cholesterol Lowering Drug Repetha

Repatha is prescribed for those patients on whom the available medications have failed to bring down the so-called LDL (low-density lipoprotein) bad cholesterol or if those are having side effects. Until now Statin is prescribed to patients for the condition.

It is an injected drug and in the class of PCSK9 inhibitors.

LDL building up in our body leads the heart disease and stroke. In the US alone 20 percent of the deaths are linked to rise in LDL. About 610,000 people are killed annually due to rise in LDL.

Manufactured by Amgen, the Repatha helps in removing LDL from blood.

The usual side effects of Repatha are nasal and throat inflammation, flu, back pain, upper respiratory infection and injection-site reactions.

FDA advisory committee first recommended Repetha in June. Last month Europe approved the drug.


Leave a Reply

Show Buttons
Hide Buttons